Effect of pomegranate seed oil on the expression of PPAR-c and pro-inflammatory biomarkers in obese type 2 diabetic patients
Effect of pomegranate seed oil on the expression of PPAR-c and pro-inflammatory biomarkers in obese type 2 diabetic patients
نویسندگان: یاسر خواجه بیشک , حامد همیشه کار , محمدرضا علی وند , مهدیه علیپور , بیت الله علیپور
کلمات کلیدی: Lipid profile, Cytokines, Pomegranate seed oil, PPAR-c, Punicic acid, Type 2 diabetes
نشریه: 25875 , 0 , 0 , 2019
| نویسنده ثبت کننده مقاله |
یاسر خواجه بیشک |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
دانشکده تغذیه |
| کد مقاله |
66402 |
| عنوان فارسی مقاله |
Effect of pomegranate seed oil on the expression of PPAR-c and pro-inflammatory biomarkers in obese type 2 diabetic patients |
| عنوان لاتین مقاله |
Effect of pomegranate seed oil on the expression of PPAR-c and pro-inflammatory biomarkers in obese type 2 diabetic patients |
| ناشر |
7 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
بلی |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
|
| Purpose
Diabetes is one of the most prevailed chronic diseases in the world. Pro-inflammatory cytokines play a key role in the type 2 diabetes mellitus. Pomegranate seed oil (PSO) has potential anti-inflammatory properties. The purpose of this study is to evaluate the antidiabetic effects of the use of PSO on the expression of peroxisome proliferator-activated receptor-gamma (PPAR-γ), pro-inflammatory biomarkers and lipid profile levels in obese type 2 diabetic patients.
Design/methodology/approach
In total, 52 patients were randomly assigned to the PSO (n = 26) and placebo (n = 26) groups. Subjects received daily PSO 3 g placebo (paraffin) in 1 g soft-gel capsules (along with breakfast, lunch and dinner meals) for eight weeks.
Findings
Serum levels of fasting blood sugar (FBS) decreased from 161.46 ± 34.44 to 143.50 ± 24.2 mg/dL (p = 0.008), IL-6 decreased from 5.17 ± 2.25 to 4.52 ± 1.90 (p = 0.049) and tumor necrosis factor alpha (TNF-a) significantly decreased from 9.17 6 4.13 to 7.74 6 2.44 pmol/mL in PSO group (p = 0.030). However, changes in the expression of PPAR-g gene, serum levels of hs-CRP and lipid profile levels were not significant.
Research limitations/implications – Lack of PSO concentration measurements and the short duration
of the study were the key limitations. Future randomized clinical trials with a longer period of follow-up are
needed to assess the potential anti-diabetic effects of PSO.
Originality/value – Administration of PSO in obese type 2 diabetic patients reduced the levels of FBS,interleukin6andTNF-a; nevertheless, changes in the insulin, lipid profiles and hs-CRP were not significant. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| IMG-20190617-WA0001.jpg | 1398/03/28 | 28823 | دانلود |
| article 2 full.pdf | 1398/01/26 | 198265 | دانلود |